Quantcast

Latest Systemic scleroderma Stories

2011-05-02 10:00:00

SAN DIEGO, May 2, 2011 /PRNewswire/ -- Amira Pharmaceuticals, Inc. announced today initial positive data from a Phase 1 clinical study of AM152, the Company's oral selective antagonist of the LPA1 receptor. Completion of this study positions Amira to initiate a Phase 2a study in patients suffering from systemic sclerosis, a systemic fibrotic disease, by early 2012. "The Phase 1 clinical study in healthy volunteers demonstrated that AM152 is safe and well-tolerated at doses which are...

2011-03-28 17:19:49

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevecâ“ž¢ (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive. "This...

2011-03-08 15:44:12

Modified-release therapy is well tolerated in clinical trial Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud's phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor or moderate side effects. Full findings are available in the March...

2010-11-08 11:17:42

New research from Georgetown University Medical Center (GUMC) suggests that up to 40 percent of scleroderma patients will not be correctly diagnosed with the disorder using a new automated commercial screening test. The findings of the study will be presented Wednesday, November 10th at the Annual Scientific Meeting of the American College of Rheumatology in Atlanta, Georgia. The American College of Rheumatology recommends immunofluorescence antinuclear antibody (IF-ANA) testing to help...

2010-09-30 12:42:00

DANVERS, Mass., Sept. 30 /PRNewswire-USNewswire/ -- The Scleroderma Foundation applauds the U.S. House of Representatives today for the passage of the Scleroderma Research and Awareness Act (H.R. 2408), introduced last March by Rep. Lois Capps (D-CA) and Rep. Vern Ehlers (R-MI). This bipartisan legislation gives hope to the estimated 300,000 Americans and their families living with this devastating disease. Scleroderma is a chronic and disabling connective tissue disorder resulting from...

2010-08-18 14:00:00

Golf Tournament to Raise Funds for the Scleroderma Foundation, Southern California Chapter LOS ANGELES, Aug. 18 /PRNewswire-USNewswire/ -- The 2nd Annual "Fight for Lexi" Charity Golf Tournament takes place on Monday, August 23, 2010 at the Dove Canyon County Club. Proceeds from the event will benefit the Scleroderma Foundation/ Southern California Chapter. The event kicks off with a shotgun start at 10:30 a.m., and will be followed by a silent auction and awards dinner. The event...

2010-06-21 08:00:00

DALLAS, June 21 /PRNewswire-USNewswire/ -- The Scleroderma Foundation's Texas Bluebonnet Chapter is pleased to announce its third annual Dallas/Fort Worth "Stepping Out to Cure Scleroderma" walk-a-thon to benefit the programs and services of the chapter and to help fund medical research aimed at finding the cause and cure for scleroderma, a little-known but devastating autoimmune disease. The walk will begin at 8:30 a.m. on Saturday, June 26, 2010 at the Collin Creek Mall in Plano, TX, and...

2010-06-15 00:25:19

There is a new path to defeat systemic sclerosis, also called scleroderma because of the hardening of the skin of the patients (from Greek skleros, "hard", and derma, "skin"). This path involves the B-cell of the immune system, so far only considered "innocent spectators," as Catholic University rheumatologist Gianfranco Ferraccioli, among the authors of the important research, puts it. Also Silvia Bosello, Maria De Santis, Gina Lama, Cristina Spanò, Cristiana Angelucci,...

2010-06-02 08:00:00

DANVERS, Mass., June 2, /PRNewswire-USNewswire/ -- Dedicated to serving the needs of those whose lives have been impacted by scleroderma through its three-fold mission of support, education and research, the Scleroderma Foundation is proud to announce June as "Scleroderma Awareness Month." During June Scleroderma Awareness Month, the Foundation focuses on efforts to advance awareness about scleroderma to a variety of audiences on local and national levels, including medical professionals,...

2010-05-04 11:00:00

DANVERS, Mass., May 4 /PRNewswire-USNewswire/ -- The Scleroderma Foundation announces an open call for proposals for its 2011 Research Grant Program. The Scleroderma Foundation fosters the development of innovative, high-quality research by new and established investigators in fields related to systemic sclerosis (SSc, scleroderma). To accomplish this goal, two distinct research grants are being offered, "Scleroderma Foundation New Investigator Grant," and the "Scleroderma Foundation...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'